Smith Group Asset Management, LLC Dr Reddys Laboratories LTD Transaction History

Smith Group Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$64.27 - $69.9 $725,608 - $789,171	-11,290 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$48.27 - $65.25 $4,827 - $6,525	-100 Reduced 0.88%	11,290 $629,000
Q4 2021 Feb 02, 2022	SELL	$59.5 - $67.25 $17,850 - $20,175	-300 Reduced 2.57%	11,390 $745,000
Q3 2021 Nov 12, 2021	BUY	$60.19 - $75.29 $703,621 - $880,140	11,690 New	11,690 $761,000

244

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.34B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Group Asset Management, LLC with notifications on news.